AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Evolent Health, Inc. Director's Dealing 2021

Mar 4, 2021

32214_dirs_2021-03-03_bb8c9766-78a4-4f99-9ac0-580c3b8e5c68.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Evolent Health, Inc. (EVH)
CIK: 0001628908
Period of Report: 2021-03-01

Reporting Person: Johnson John Paul (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-01	Class A Common Stock	A	40000	—	Acquired	136921	Direct

Footnotes

F1: Includes restricted stock units granted to Mr. Johnson pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2: Securities vest at a rate of 25% annually beginning March 1, 2022.

F3: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.